Terms: = Head and neck cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568
452 results:
1. Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.
Maia A; Tarannum M; Lérias JR; Piccinelli S; Borrego LM; Maeurer M; Romee R; Castillo-Martin M
Cells; 2024 Mar; 13(5):. PubMed ID: 38474415
[TBL] [Abstract] [Full Text] [Related]
2. Three Artemisia pollens trigger the onset of allergic rhinitis via TLR4/MyD88 signaling pathway.
Zhang J; Gao L; Yu D; Song Y; Zhao Y; Feng Y
Mol Biol Rep; 2024 Feb; 51(1):319. PubMed ID: 38388914
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic DNA mutation and mRNA expression analysis of perineural invasion in oral squamous cell carcinoma.
Kuk SK; Kim K; Lee JI; Pang K
Sci Rep; 2024 Jan; 14(1):2427. PubMed ID: 38287071
[TBL] [Abstract] [Full Text] [Related]
4. NK cells propagate T cell immunity following in situ tumor vaccination.
Jin WJ; Jagodinsky JC; Vera JM; Clark PA; Zuleger CL; Erbe AK; Ong IM; Le T; Tetreault K; Berg T; Rakhmilevich AL; Kim K; Newton MA; Albertini MR; Sondel PM; Morris ZS
Cell Rep; 2023 Dec; 42(12):113556. PubMed ID: 38096050
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-infiltrating immune cell score as an independent prognostic predictor for endometrial carcinoma: Insights from a comprehensive analysis of the immune landscape.
Zhang L; Zhu Q; Zhao Q; Lin X; Song H; Liu H; Zhu G; Lu S; Cao B
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1939. PubMed ID: 38017652
[TBL] [Abstract] [Full Text] [Related]
6. Changes of immune microenvironment in head and neck squamous cell carcinoma in 3D-4-culture compared to 2D-4-culture.
Xiao J; Song Y; Gao R; You M; Deng C; Tan G; Li W
J Transl Med; 2023 Oct; 21(1):771. PubMed ID: 37907991
[TBL] [Abstract] [Full Text] [Related]
7. Selective targeting of il2Rβγ combined with radiotherapy triggers CD8- and NK-mediated immunity, abrogating metastasis in HNSCC.
Gadwa J; Amann M; Bickett TE; Knitz MW; Darragh LB; Piper M; Van Court B; Bukkapatnam S; Pham TT; Wang XJ; Saviola AJ; Deak LC; Umaña P; Klein C; D'Alessandro A; Karam SD
Cell Rep Med; 2023 Aug; 4(8):101150. PubMed ID: 37586327
[TBL] [Abstract] [Full Text] [Related]
8. IL-17 A correlates with disease progression in papillary thyroid carcinoma.
Banerjee S; Nahar U; Dahiya D; Gupta R; Mukherjee S; Sachdeva N; Sood A; Dey P; Radotra B; Bhansali A
Diagn Pathol; 2023 Aug; 18(1):93. PubMed ID: 37563607
[TBL] [Abstract] [Full Text] [Related]
9. Bispecific anti-CD3×anti-CD155 antibody mediates T-cell immunotherapy in human haematologic malignancies.
Ma L; Ma J; Sun X; Liu H
Invest New Drugs; 2023 Jun; 41(3):522-531. PubMed ID: 37198354
[TBL] [Abstract] [Full Text] [Related]
10. Network Toxicology Prediction and Molecular Docking-based Strategy to Explore the Potential Toxicity Mechanism of Metformin Chlorination Byproducts in Drinking Water.
Zhang GH; Liu H; Liu MH; Liu YC; Wang JQ; Wang Y; Wang X; Xiang Z; Liu W
Comb Chem High Throughput Screen; 2024; 27(1):101-117. PubMed ID: 37170985
[TBL] [Abstract] [Full Text] [Related]
11. T-cell exhaustion: A potential target biomarker of the tumour microenvironment affecting oesophageal adenocarcinoma.
Peng S; Han X; Geng W; Zhao L
J Gene Med; 2023 Jul; 25(7):e3496. PubMed ID: 36879295
[TBL] [Abstract] [Full Text] [Related]
12. Correlations between the severity of radiation-induced oral mucositis and salivary epidermal growth factor as well as inflammatory cytokines in patients with head and neck cancer.
Xu J; Yang G; An W; Wang W; Li F; Meng Y; Wang X
Head Neck; 2023 May; 45(5):1122-1129. PubMed ID: 36866530
[TBL] [Abstract] [Full Text] [Related]
13. Single-cell RNA sequencing identifies a population of human liver-type ILC1s.
Krämer B; Nalin AP; Ma F; Eickhoff S; Lutz P; Leonardelli S; Goeser F; Finnemann C; Hack G; Raabe J; ToVinh M; Ahmad S; Hoffmeister C; Kaiser KM; Manekeller S; Branchi V; Bald T; Hölzel M; Hüneburg R; Nischalke HD; Semaan A; Langhans B; Kaczmarek DJ; Benner B; Lordo MR; Kowalski J; Gerhardt A; Timm J; Toma M; Mohr R; Türler A; Charpentier A; van Bremen T; Feldmann G; Sattler A; Kotsch K; Abdallah AT; Strassburg CP; Spengler U; Carson WE; Mundy-Bosse BL; Pellegrini M; O'Sullivan TE; Freud AG; Nattermann J
Cell Rep; 2023 Jan; 42(1):111937. PubMed ID: 36640314
[TBL] [Abstract] [Full Text] [Related]
14. Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancer.
Karbach J; Kiselicki D; Brand K; Wahle C; Sinelnikov E; Gustavus D; Hoffmeister H; Prisack HB; Atmaca A; Jäger E
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36627144
[TBL] [Abstract] [Full Text] [Related]
15. EGF‑il2 bispecific and bivalent EGF fusion toxin efficacy against syngeneic head and neck cancer mouse models.
Qiu Y; Qi Z; Wang Z; Cao Y; Lu L; Zhang H; Mathes D; Pomfret EA; Lu SL; Wang Z
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36579667
[TBL] [Abstract] [Full Text] [Related]
16. Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines.
Lee J; Keam B; Park HR; Park JE; Kim S; Kim M; Kim TM; Kim DW; Heo DS
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5705-5715. PubMed ID: 36547689
[TBL] [Abstract] [Full Text] [Related]
17. Synthetic cytokine circuits that drive T cells into immune-excluded tumors.
Allen GM; Frankel NW; Reddy NR; Bhargava HK; Yoshida MA; Stark SR; Purl M; Lee J; Yee JL; Yu W; Li AW; Garcia KC; El-Samad H; Roybal KT; Spitzer MH; Lim WA
Science; 2022 Dec; 378(6625):eaba1624. PubMed ID: 36520915
[TBL] [Abstract] [Full Text] [Related]
18. The Predicting Role of Serum TSGF and sil-2R for the Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Xu X; Wang W; Sun T; Tian B; Du L; Jing J
Dis Markers; 2022; 2022():3730679. PubMed ID: 36092957
[TBL] [Abstract] [Full Text] [Related]
19. The influence of thyroid hormone medication on intra-therapeutic half-life of
Happel C; Kranert WT; Bockisch B; Sabet A; Grünwald F; Groener D
Sci Rep; 2022 Aug; 12(1):13925. PubMed ID: 35978004
[TBL] [Abstract] [Full Text] [Related]
20. Natural killer cells have a synergistic anti-tumor effect in combination with chemoradiotherapy against head and neck cancer.
Jung EK; Chu TH; Vo MC; Nguyen HPQ; Lee DH; Lee JK; Lim SC; Jung SH; Yoon TM; Yoon MS; Cho D; Lee JJ; Cho HH
Cytotherapy; 2022 Sep; 24(9):905-915. PubMed ID: 35778350
[TBL] [Abstract] [Full Text] [Related]
[Next]
